Traditional medicines: WHO supports NIPRD, NAFDAC to ensure products scale through Essential Medicines List

By Hassan Zaggi

The World Health Organisation (WHO) has vowed to continue to provide technical assistance to the National Institute of Pharmaceutical Research and Development (NPRD) and the National Agency for Food and Drug Administration and Control (NAFDAC) in improving the quality of medicinal products and ensure the listing of the products in the National Essential Medicines List.

The WHO Country Representative in Nigeria, Dr Walter Kazadi Mulombo, stated this at the commemoration of 2021 Traditional Medicine Day, in Abuja, Monday.  

Represented by Dr. Kofi Boateng EPI Focal Point , Universal Health Coverage(UHC), the Country Representative disclosed that the WHO Nigeria has taken it up to support the Federal Ministry of Health “and in particular the department of Traditional, Complementary and Alternative Medicines, in the review of the Traditional Medicines Policy 2007, review of the Nigeria Pharmacopoeia 2008 and the development of a 5-year strategic plan to implement the new policy and the revised pharmacopoeia.”  

He noted that the WHO remained committed to supporting the Government of Nigeria in its goal of achieving self-sufficiency in the local production of pharmaceuticals (including Vaccines), traditional medicine and researches.

The WHO Country Representative noted that Africa has a long history of traditional medicine and practitioners that play an important role in providing care to populations over the centuries. The African Heads of State in 2001, declared traditional medicine research a priority and subsequently designated the next 10 years as decade of African Traditional Medicine which was extended to the year 2020.

According to him: “For the past 20 years, countries in the WHO African Regional Office have marked the African Traditional Medicine Day on 31st of August each year. WHO advocate for strengthening the linkage between traditional medicine and institutionalized care in line with the WHO strategy.

“We are still battling the COVID-19 pandemic. WHO recognizes that traditional, complementary and alternative medicine has many benefits when properly harnessed with. Therefore, researches into our traditional medicines is an effort in the right direction.”

While commending the federal government for its efforts in developing herbal medicine in the country, the WHO Country Representative said: “The listing of 14 herbal medicinal products by NAFDAC against COVID-19 and ongoing clinical trials on them, is in line with the Regional Expert Committee on COVID-19 aim of elevating the standards of clinical trials of traditional medicine for COVID-19.

“The ongoing research(s) in the National Institute for Pharmaceutical Research & Development and other higher institutions, highlights the interest of the Government of Nigeria to develop and promote African Traditional Medicines.”

Speaking earlier, the Minister of State for Health, Adeleke Mamora, said that his ministry has begun the process of reviewing the traditional medicine policy. 

“All these measures are aimed at strengthening our resources for delivery of qualitative and safe traditional medicine. Also we  have put in placed an experts committee for the setting up of traditional Complementary and Alternative Medicine Institute to ensure for the training of professionals in this sector. 

“The series of events during this period of COVID-19 pandemic calls for the needs to look inwards and consider local production of medicines as necessary for national health security and attainment of the universal health coverage.” You missed this story.
Good day
Show quoted text

Related Posts

Leave a Comment

This News Site uses cookies to improve reading experience. We assume this is OK but if not, please do opt-out. Accept Read More